Arachidonic acid potentiates currents through Ca2+-permeable AMPA receptors by interacting with a CaMKII pathway

Brain Res Mol Brain Res. 1999 Apr 6;67(1):184-9. doi: 10.1016/s0169-328x(99)00042-x.

Abstract

The present study investigated the effect of arachidonic acid on the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, presumably heteromeric receptors formed of GluR1, GluR2, and GluR3, expressed in Xenopus oocytes. Arachidonic acid (10 microM) potentiated currents through receptors expressing GluR1 and 3 (GluR1,3) to 170% of basal level during initial 20 min following application, being still evident at 60-min washing-out of the drug, while it never or little enhanced currents through receptors expressing GluR1 and 2 (GluR1,2) or GluR1, 2, and 3 (GluR1,2,3) (110% 30 min after treatment). The effect of arachidonic acid on GluR1,3 currents was not observed in Ca2+-free extracellular solution, and the potentiation was blocked by either KN-93, a selective Ca2+/calmodulin-dependent protein kinase II (CaMKII) inhibitor, or NP217, an active CaMKII inhibitor peptide, when co-expressed with the receptors. In contrast, the protein synthesis inhibitor, cycloheximide, the selective inhibitor of cAMP-dependent protein kinase (PKA), H-89, the selective inhibitors of protein kinase C (PKC), PKCI and GF109203X, the mitogen-activated protein (MAP) kinase kinase inhibitor, PD98059, or the inactive CaMKII inhibitors, KN-92 and NP218, had no effect on the currents. In the assay of intracellular calcium mobilizations, Ca2+ influx in response to receptor activation was greatest with receptors formed in oocytes expressing GluR1,3. The results of the present study indicate that arachidonic acid induces a long-lasting potentiation of GluR1,3 currents, possibly as a result of the interaction with a CaMKII pathway.

MeSH terms

  • Animals
  • Arachidonic Acid / pharmacology*
  • Benzylamines / pharmacology
  • Calcium / analysis
  • Calcium / metabolism*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / antagonists & inhibitors
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Excitatory Amino Acid Agonists / pharmacology
  • Flavonoids / pharmacology
  • Indoles / pharmacology
  • Ion Channel Gating / drug effects*
  • Ion Channel Gating / physiology
  • Isoquinolines / pharmacology
  • Kainic Acid / pharmacology
  • Maleimides / pharmacology
  • Oocytes / physiology
  • Patch-Clamp Techniques
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism
  • RNA, Messenger / genetics
  • Receptors, AMPA / genetics
  • Receptors, AMPA / metabolism*
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Sulfonamides / pharmacology
  • Xenopus

Substances

  • Benzylamines
  • Enzyme Inhibitors
  • Excitatory Amino Acid Agonists
  • Flavonoids
  • Indoles
  • Isoquinolines
  • Maleimides
  • RNA, Messenger
  • Receptors, AMPA
  • Sulfonamides
  • glutamate receptor ionotropic, AMPA 3
  • KN 93
  • Arachidonic Acid
  • Protein Kinase C
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • bisindolylmaleimide I
  • N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide
  • glutamate receptor ionotropic, AMPA 2
  • Kainic Acid
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Calcium
  • glutamate receptor ionotropic, AMPA 1